Ignite Creation Date:
2024-05-06 @ 7:48 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02604017
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2015-11-11
Brief Title:
A Study to Evaluate the Efficacy and Safety of ABT-493ABT-530 in Subjects With Genotype 1 Infection
Sponsor:
AbbVie
Organization:
AbbVie
Study Overview
Official Title:
A Randomized Open-Label Multicenter Study to Evaluate the Efficacy and Safety of ABT-493ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1 Infection ENDURANCE-1
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study seeks to evaluate the efficacy and safety of ABT-493ABT-530 in participants with Genotype 1 hepatitis C virus infection without cirrhosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2015-002087-17 | EUDRACT_NUMBER | None | None |